Hosted on MSN11mon
GSK expands Asia-Pacific reach for Trelegy Ellipta with Singapore approval
Singapore’s Health Sciences Authority (HSA) has expanded the label of GlaxoSmithKline (GSK)’s Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) to ...
Bloomberg on MSN10mon
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay
(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer ...
The Business Times4d
Pfizer sells entire Haleon stake for US$3.24 billion
Bengaluru] Drugmaker Pfizer has sold its entire stake in Haleon for about US$3.24 billion to institutional investors and the ...
pharmaphorum2d
AbbVie invests $223m in Singapore biologics site
GSK, Pfizer, Sanofi, MSD, Novartis, and Roche among AbbVie’s neighbours. “We are grateful for AbbVie’s continued trust in the strength of Singapore’s biopharmaceutical manufacturing ...
manilatimes12d
Report: RSV-associated Hospitalisation Costs in Singapore Estimated at SGD 9,430 per Patient; Poses Financial Strain on At-risk Older Adults
8-10 Dr Lee Tau Hong, Infectious Disease Specialist, Infectious Diseases Care Clinic in Singapore, shared with GSK, "RSV poses a significant burden on patients, families, and healthcare systems ...
Yahoo Finance1mon
GSK’s Sluggish Shares Seen at Risk of New Activist Campaign
(Bloomberg) -- GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine sales falling, some market participants say it may draw ...